These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

752 related items for PubMed ID: 8984692

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Current status of clinical indications for hematopoietic growth factors after chemo-/radiotherapy in gynecology].
    Karthaus M, Ganser A.
    Zentralbl Gynakol; 1997; 119(12):585-96. PubMed ID: 9483809
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O, Foss B, Petersen H.
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical applications of recombinant human colony-stimulating factors.
    Klingemann HG.
    CMAJ; 1989 Jan 15; 140(2):137-42. PubMed ID: 2642725
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R, Borota J, Belić A, Gebauer E, Stefanović N.
    Med Pregl; 1997 Jan 15; 50(3-4):87-93. PubMed ID: 9229690
    [Abstract] [Full Text] [Related]

  • 13. Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome.
    Herrmann F, Mertelsmann R, Lindemann A, Ottmann OG, Seipelt G, Oster W, Hoelzer D, Ganser A.
    Biotechnol Ther; 1991 Jan 15; 2(3-4):299-311. PubMed ID: 1845132
    [Abstract] [Full Text] [Related]

  • 14. G-CSF and GM-CSF in clinical trials.
    Antman KH.
    Yale J Biol Med; 1990 Jan 15; 63(5):387-410. PubMed ID: 1705737
    [Abstract] [Full Text] [Related]

  • 15. [Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO)].
    Motoyoshi K.
    Nihon Rinsho; 1992 Aug 15; 50(8):1967-72. PubMed ID: 1279240
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 15; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 18. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR.
    J Natl Cancer Inst; 2007 Feb 07; 99(3):196-205. PubMed ID: 17284714
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Colony stimulating factors.
    Klingemann HG, Eaves CJ.
    Bone Marrow Transplant; 1988 May 07; 3(3):177-84. PubMed ID: 2458788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.